SecBot SecBot
144 ·Filed Jun 26, 2026

IMVT

Immunovant, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed4mo ago SEC0001950047-26-006543
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine insider intent-to-sell filing with no material implications. Monitor for subsequent Form 4 filing to confirm execution, but no trading action warranted.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
IMVT ▼ -3.17% at T+60d
NEUTRAL call -3.17% · α vs SPY -7.55% · entry $38.51 → $37.29
Entry = T+0 close
Jun 26, 2026
via day close
T+1d
+0.05%
call +0.05% · α -0.73%
$38.53
settled 4mo ago
T+5d
+0.23%
call +0.23% · α -1.15%
$38.60
settled 4mo ago
T+20d
+2.34%
call +2.34% · α +2.62%
$39.41
settled 3mo ago
T+60d
-3.17%
call -3.17% · α -7.55%
$37.29
settled 5w ago

Price Chart

Loading chart...

Executive Summary

Officer Jay S. Stout filed a Form 144 indicating intent to sell 40,000 shares of Immunovant common stock, valued at approximately $1.53 million. The shares were acquired through restricted stock vesting, and the sale appears routine for diversification or tax purposes. Given the small size relative to the $7.9B market cap, this filing has negligible market impact.

Key Facts

  • Officer Jay S. Stout filed Form 144 to sell 40,000 shares of IMVT common stock.
  • Estimated market value of the proposed sale is $1,532,196 (approx. $38.30/share).
  • Shares were acquired through restricted stock vesting under a registered plan on various dates in 2024 and 2026.
  • Filing date: June 26, 2026.

Financial Impact

Proposed sale of 40,000 shares valued at ~$1.53M, representing less than 0.001% of market cap.

dilution

Risk Factors

  • None material; sale is small and likely for personal liquidity.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
75% bullish (24 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-006543
Document: 0001950047-26-006543-index.html0001950047-26-006543
Document: 0001950047-26-006543.txt0001950047-26-006543
12 reports for IMVT
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for IMVT — sortable, filterable
TypeNow
Aug 6, 2026
11w ago
8-K
BEARISH ★ 6/10
$39.74 $39.12▲ +1.56%▲ +2.16%$27.68 (+30.35%)
Jul 24, 2026
13w ago
Insider Cluster
NEUTRAL ★ 2/10
$40.09 $43.32▲ +8.06%▲ +4.76%$27.68 (−30.96%)
Jun 26, 2026
17w ago
Insider Cluster
NEUTRAL ★ 3/10
$38.51 $39.41▲ +2.34%▲ +2.62%$27.68 (−28.12%)
Jun 26, 2026
17w ago
Insider Cluster
NEUTRAL ★ 2/10
$38.51 $39.41▲ +2.34%▲ +2.62%$27.68 (−28.12%)
Jun 26, 2026
17w ago
144
NEUTRAL ★ 2/10
$38.51 $39.41▲ +2.34%▲ +2.62%$27.68 (−28.12%)
Jun 26, 2026
17w ago
144
NEUTRAL ★ 4/10
$38.51 $39.41▲ +2.34%▲ +2.62%$27.68 (−28.12%)
Jun 15, 2026
18w ago
144
NEUTRAL ★ 2/10
$33.61 $38.77▲ +15.35%▲ +15.15%$27.68 (−17.64%)
May 28, 2026
21w ago
144
NEUTRAL ★ 3/10
$33.30 $38.51▲ +15.65%▲ +17.44%$27.68 (−16.88%)
May 20, 2026
22w ago
8-K
MIXED ★ 6/10
$35.56 $35.34▼ −0.62%▼ −1.36%$27.68 (−22.16%)
May 20, 2026
22w ago
Press Release
BULLISH ★ 7/10
$35.56 $35.34▼ −0.62%▼ −1.36%$27.68 (−22.16%)
Showing 10 of 12

US Market Status

Market Open — Closes in 5h 16m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 26, 2026